TherapeuticsMD Inc (TXMD)
2.31
-0.09
(-3.75%)
USD |
NASDAQ |
Mar 18, 16:00
2.36
+0.05
(+2.16%)
After-Hours: 20:00
Price Chart
Key Stats
Price and Performance | |
---|---|
Market Cap | 24.43M |
52 Week High (Daily) | Upgrade |
52 Week Low (Daily) | Upgrade |
All-Time High (Daily) | Upgrade |
Year to Date Total Returns (Daily) | Upgrade |
1 Month Total Returns (Daily) | Upgrade |
1 Year Total Returns (Daily) | -33.62% |
Valuation | |
PE Ratio | 0.3222 |
PE Ratio (Forward) | Upgrade |
PS Ratio | 0.3456 |
Price to Book Value | 0.8708 |
EV to EBITDA | Upgrade |
Dividend | |
---|---|
Dividend | -- |
Dividend Yield (Forward) | Upgrade |
Financials | |
Revenue (5 Year Growth) | Upgrade |
Revenue (Quarterly YoY Growth) | Upgrade |
EPS Diluted (5 Year Growth) | Upgrade |
EPS Diluted (Quarterly YoY Growth) | Upgrade |
Debt to Equity Ratio | 0.00 |
Return on Equity | Upgrade |
Return on Assets | Upgrade |
Risk | |
Beta (5Y) | Upgrade |
Max Drawdown (5Y) | 99.44% |
Profile
TherapeuticsMD Inc is a major drug manufacturing with a focus on creating and commercializing products targeted exclusively for women. The company intends to commercialize advanced hormone therapy pharmaceutical products. TherapeuticsMD's drug candidates that have completed clinical trials are designed to alleviate the symptoms of and reduce the health risks resulting from menopause-related hormone deficiencies, including hot flashes, osteoporosis, and discomfort. The company relies on third parties for the production of clinical and commercial quantities of its drug candidates. |
URL | https://www.therapeuticsmd.com |
Investor Relations URL | http://ir.therapeuticsmd.com/ |
HQ State/Province | Florida |
Sector | Healthcare |
Industry | Drug Manufacturers - Specialty & Generic |
Equity Style | Small Cap/Growth |
Next Earnings Release | Apr. 05, 2024 (est.) |
Last Earnings Release | Nov. 14, 2023 |
Next Ex-Dividend Date | N/A |
Last Ex-Dividend Date | N/A |
Ratings
Profile
TherapeuticsMD Inc is a major drug manufacturing with a focus on creating and commercializing products targeted exclusively for women. The company intends to commercialize advanced hormone therapy pharmaceutical products. TherapeuticsMD's drug candidates that have completed clinical trials are designed to alleviate the symptoms of and reduce the health risks resulting from menopause-related hormone deficiencies, including hot flashes, osteoporosis, and discomfort. The company relies on third parties for the production of clinical and commercial quantities of its drug candidates. |
URL | https://www.therapeuticsmd.com |
Investor Relations URL | http://ir.therapeuticsmd.com/ |
HQ State/Province | Florida |
Sector | Healthcare |
Industry | Drug Manufacturers - Specialty & Generic |
Equity Style | Small Cap/Growth |
Next Earnings Release | Apr. 05, 2024 (est.) |
Last Earnings Release | Nov. 14, 2023 |
Next Ex-Dividend Date | N/A |
Last Ex-Dividend Date | N/A |